logo
logo

Pbs Biotech Raises $22M To Expand Single-Use Manufacturing Products And Services For Cell Therapy Clients

Jan 09, 2023•over 2 years ago

Amount Raised

$22 Million

CamarilloAgriculture And FarmingBiotechnologyManufacturingScience And EngineeringHealth CareSoftwareEducation

Investors

Broad Oak Capital PartnersAvego Management, Llc

Description

PBS Biotech ("PBS"), an innovative, single-use bioreactor manufacturer and process development services provider, has completed a $22 million financing led by Avego Management, LLC ("Avego") with additional investment from existing investor BroadOak Capital Partners ("BroadOak"). This financing will be used to improve the company's products portfolio, expand its process development services capability, and increase customer support for global cell therapy clients.

Company Information

Company

PBS Biotech

Location

Camarillo, California, United States

About

PBS Biotech is a leading manufacturer of single-use bioreactor systems and provider of process development services. PBS' bioreactors utilize proprietary Vertical-Wheel® technology to create homogeneous and scalable mixing conditions for a variety of sensitive cell therapy products and cell culture applications. PBS Biotech's vision is to become the world's standard manufacturing platform for allogeneic cell-based therapies.

Related People

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech